0001209191-21-056623.txt : 20210917 0001209191-21-056623.hdr.sgml : 20210917 20210917161152 ACCESSION NUMBER: 0001209191-21-056623 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210915 FILED AS OF DATE: 20210917 DATE AS OF CHANGE: 20210917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OSTADAN OMEAD CENTRAL INDEX KEY: 0001642678 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39747 FILM NUMBER: 211260548 MAIL ADDRESS: STREET 1: C/O SEER, INC. STREET 2: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seer, Inc. CENTRAL INDEX KEY: 0001726445 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 821153150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-453-0000 MAIL ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Seer Biosciences, Inc. DATE OF NAME CHANGE: 20171226 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-15 0 0001726445 Seer, Inc. SEER 0001642678 OSTADAN OMEAD C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065 1 1 0 0 President & COO Class A Common Stock 2021-09-15 4 C 0 20000 2.70 A 397448 D Class A Common Stock 2021-09-15 4 S 0 5121 40.2936 D 392327 D Class A Common Stock 2021-09-15 4 S 0 12620 41.034 D 379707 D Class A Common Stock 2021-09-15 4 S 0 2259 41.8432 D 377448 D Employee Stock Option (right to buy) 2.70 2021-09-15 4 M 0 20000 0.00 D 2030-03-05 Class A Common Stock 20000 345481 D Employee Stock Option (right to buy) 2.70 2030-03-05 Class A Common Stock 852793 852793 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.64 to $40.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.64 to $41.63, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.65 to $42.14, inclusive. The shares underlying the option are subject to an early exercise provision and are immediately exercisable. The shares underlying the option vest in 48 equal monthly installments beginning on April 6, 2020. The shares underlying the option are subject to an early exercise provision and are immediately exercisable. One-fourth of the shares underlying the option vest on June 15, 2021 and 1/48th of the shares vest monthly thereafter. /s/ Elona Kogan, by power of attorney 2021-09-17